Clinical Trial Update: Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a dendritic cell vaccine loaded with allogeneic cell lysate in patients with mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Dendritic cell vaccine (allogeneic cell lysate-loaded) (Dendritic cell vaccine)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Mesothelioma | Phase 1 | Status: UNKNOWN